tailieunhanh - Efficacy of adjuvant chemotherapy stratified by age and the 21-gene recurrence score in estrogen receptorpositive breast cancer

The 21-gene recurrence score (RS) can predict chemotherapy benefit in estrogen receptor-positive, human epidermal growth factor receptor-2-negative (ER+/HER2-) early breast cancer patients. Age would influence the interaction between RS and chemotherapy effect. The current study aimed to determine RS thresholds which were predictive of chemotherapy benefit in young and old women, respectively |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN